Уромодулин и выраженность тубулоинтерстициальных повреждений у пациентов с нефропатиями
Аннотация
Об авторах
А. В. СмирновРоссия
М. . Хасун
Россия
И. Г. Каюков
Россия
В. Г. Сиповский
Россия
О. В. Галкина
Россия
И. М. Зубина
Россия
А. Г. Кучер
Россия
Р. В. Зверьков
Россия
А. В. Карунная
Россия
Список литературы
1. Youhanna S., Weber J., Beaujean V. et al. Determination of uromodulin in human urine: influence of storage and processing. Nephrol Dial Transplant 2014; 29(1): 136-145
2. Зверев Я.Ф., Жариков А.Ю., Брюханов В.М., Лампатов В.В. Модуляторы оксалатного нефролитиаза. Ингибиторы кристаллизации. Нефрология 2010; 14(1): 29-49
3. El-Achkar T.M., Wu X.R. Uromodulin in kidney injury: an instigator, bystander, or protector? Am J Kidney Dis 2012; 59(3): 452-461
4. El-Achkar T.M., McCracken R., Liu Y. et al. Tamm-Horsfall protein translocates to the basolateral domain of thick ascending limbs, interstitium, and circulation during recovery from acute kidney injury. Am J Physiol Renal Physiol 2013; 304(8): F1066-F1075
5. Graterol F., Navarro-Muñoz M., Ibernon M. et al. Poor histological lesions in IgA nephropathy may be reflected in blood and urine peptide profiling. BMC Nephrol 2013 Apr 11; 14: 82. doi: 10.1186/1471-2369-14-82
6. Padmanabhan S., Melander O., Johnson T. et al. Genome-wide association study of blood pressure extremes identifies variant near UMOD associated with hypertension. PLoS Genet 2010 Oct 28; 6(10): e1001177. doi: 10.1371/journal.pgen.1001177
7. Graham L.A., Padmanabhan S., Fraser N.J. et al. Validation of uromodulin as a candidate gene for human essential hypertension. Hypertension 2014; 63(3): 551-558
8. Han J., Chen Y., Liu Y.et al. Common variants of the UMOD promoter associated with blood pressure in a community-based Chinese cohort. Hypertens Res 2012; 35(7): 769-774
9. Kirk R. Hypertension: Uromodulin identified as a potential therapeutic target. Nat Rev Nephrol 2014; 10(1): 2. doi: 10.1038/ nrneph.2013.241
10. Lhotta K. Uromodulin and chronic kidney disease. Kidney Blood Press Res 2010; 33(5): 393-398
11. Moskowitz J.L., Piret S.E., Lhotta K. et al. Association between genotype and phenotype in uromodulin-associated kidney disease. Clin J Am Soc Nephrol 2013; 8(8): 1349-1357
12. Srichai M.B., Hao C., Davis L. et al. Apoptosis of the thick ascending limb results in acute kidney injury. J Am Soc Nephrol 2008; 19: 1538-1546
13. El-Achkar T.M., Wu X.R., Rauchman M. et al. Tamm-Horsfall protein protects the kidney from ischemic injury by decreasing inflammation and altering TLR4 expression. Am J Physiol Renal Physiol 2008; 295: F534-F544
14. Mao S., Zhang A., Huang S. The signaling pathway of uromodulin and its role in kidney diseases. J Recept Signal Transduct Res 2014; 34(6): 440-444
15. Bates J.M., Raffi H.M., Prasadan K. et al. Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004; 65: 791-797
16. Serafini-Cessi F., Monti A., Cavallone D. N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases. Glycoconj J 2005; 22: 383-394
17. Saemann M.D., Weichhart T., Zeyda M. et al. Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 2005; 115: 468-475
18. Raffi H., Bates J., Kumar S. et al. Tamm-Horsfall protein knockout mice have increased stress induced micturition. Neurou-rol Urodyn 2009; 28: 469-478
19. Boger C.A., Gorski M., Li M. et al. Association of eGFR-related loci identified by GWAS with incident CKD and ESRD. PLoS Genet 2011; 7(9): e1002292. doi: 10.1371/journal.pgen.1002292
20. Reznichenko A., Böger C.A., Snieder H. et al. UMOD as a susceptibility gene for end-stage renal disease. BMC Med Genet 2012 Sep 5; 13: 78. doi: 10.1186/1471-2350-13-78
21. Köttgen A., Hwang S.J., Larson M.G. et al. Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol 2010; 21(2): 337-344
22. Gudbjartsson D.F., Holm H., Indridason O.S. et al. Association of variants at UMOD with chronic kidney disease and kidney stones-role of age and comorbid diseases. PLoS Genet 2010 Jul 29; 6(7): e1001039. doi: 10.1371/journal.pgen.1001039
23. Shlipak M.G., Li Y., Fox C. et al. Uromodulin concentrations are not associated with incident CKD among persons with coronary artery disease. BMC Nephrol 2011; Jan 14; 12: 2. doi: 10.1186/1471-2369-12-2
24. Zhou J, Chen Y., Liu Y. et al. Urinary uromodulin excretion predicts progression of chronic kidney disease resulting from IgA nephropathy. PLoS One 2013 Aug 22; 8(8): e71023. doi: 10.1371/journal.pone.0071023.eCollection2013
25. Prajczer S., Heidenreich U., Pfaller W. et al. Evidence for a role of uromodulin in chronic kidney disease progression. Nephrol Dial Transplant 2010; 25(6): 1896-1903
26. Risch L., Lhotta K., Meier D. et al. The serum uromodulin level is associated with kidney function. Clin Chem Lab Med 2014; 52(12): 1755-1761
27. Mutig K., Kahl T., Saritas T., Godes M. Activation of the bumetanide-sensitive Na+,K+,2Cl- cotransporter (NKCC2) is facilitated by Tamm-Horsfall protein in a chloride-sensitive manner. Biol Chem 2011; 286 (34): 30200-30210
Рецензия
Для цитирования:
Смирнов А.В., Хасун М., Каюков И.Г., Сиповский В.Г., Галкина О.В., Зубина И.М., Кучер А.Г., Зверьков Р.В., Карунная А.В. Уромодулин и выраженность тубулоинтерстициальных повреждений у пациентов с нефропатиями. Нефрология. 2015;19(2):49-54.
For citation:
Smirnov A.V., Khasun M., Kayukov I.G., Sipovsky V.G., Galkina O.V., Zubina I.M., Kucher A.G., Zverkov R.V., Karunnaya H.V. Uromodulin and severity of tubulointerstitial lesions in patients with nephropathies. Nephrology (Saint-Petersburg). 2015;19(2):49-54. (In Russ.)